Le produit a bien été ajouté au panier.

discount label
H-YMLDL^QPETT-OH
Vue en 3D

Biosynth logo

H-YMLDL^QPETT-OH

Ref. 3D-PP43487

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le jeudi 12 décembre 2024

Informations sur le produit

Nom :
H-YMLDL^QPETT-OH
Synonymes :
  • NH2-Tyr-Met-Leu-Asp-Leu^Gln-Pro-Glu-Thr-Thr-OH
Description :

Peptide H-YMLDL^QPETT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YMLDL^QPETT-OH include the following: T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor YS Lee, TS Kim, DK Kim - BMC cancer, 2011 - Springerhttps://link.springer.com/article/10.1186/1471-2407-11-225 Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo YC Song , AH Chou, A Homhuan - Journal of Leukocyte , 2011 - academic.oup.comhttps://academic.oup.com/jleukbio/article-abstract/90/2/323/6960320 Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical WMJ Schoell, R Mirhashemi, B Liu, MF Janicek - Gynecologic , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S009082589995504X Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial WJ Van Driel, ME Ressing, GG Kenter - European journal of , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804999000489 Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations WF Cheng, CN Lee, YN Su, MC Chang - , 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2005.02126.x Linear epitope prediction in HPV type 16 E7 antigen and their docked interaction with human TMEM 50A structural model U Srivastava , S Singh, B Gautam , P Yadav - , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498776/ Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous SJ Youde, PRR Dunbar , EML Evans, AN Fiander - Cancer research, 2000 - AACRhttps://aacrjournals.org/cancerres/article-abstract/60/2/365/506850 Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line SJ Youde, CM McCarthy, KJ Thomas - Journal of Cancer, 2005 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20779 A novel HLA-A2-restricted CTL epitope of tumor-associated antigen L6 can inhibit tumor growth in vivo SH Tu, HI Huang , SI Lin, HY Liu, YP Sher - Journal of , 2012 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/FullText/2012/04000/A_Novel_HLA_A2_restricted_CTL_Epitope_of.4.aspx Study on phenotype and function of antigen-specific CD8+ cytotoxic T cells induced by HPV 16 E7 peptide in vitro. QQF Qian QiFeng, LFG Li FangGu, LQ Li Qing - 2010 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20103227892 detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic N Cools , P Ponsaerts , M Lenjou, G Nijs - Molecular Cancer, 2006 - Springerhttps://link.springer.com/article/10.1186/1476-4598-5-49 A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7 (11-20) cytotoxic T lymphocyte epitope MWJ Schreurs, EWM Kueter, KBJ Scholten - Vaccine, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X05003804 Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway ML Mora-Garcaca­a , LR acavila-Ibarra, R Garcaca­a-Rocha - Cellular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874917301363 Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone ML Mora-Garcaca­a , A Duenas-Gonzalez - Journal of Translational , 2006 - Springerhttps://link.springer.com/article/10.1186/1479-5876-4-55 Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions M de Lourdes Mora-Garcaca­a , R Garcaca­a-Rocha - Journal of Translational , 2016 - Springerhttps://link.springer.com/article/10.1186/s12967-016-1057-8 Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type M Alexander, ML Salgaller, E Celis, A Sette - American journal of , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937896701102 Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein K Nilges, H Höhn, H Pilch, C Neukirch - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5464-5474.2003 Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization HW Chen, CH Leng, HY Liu, WF Cheng - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/pdf/10.4161/cbt.8.21.9732 Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A* 0201-restricted T-cell peptides in cervical cancer patients DW Liu, YC Yang, HF Lin, MF Lin, YW Cheng - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02256-06 Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens DB Keskin , B Reinhold , SY Lee, G Zhang - Frontiers in , 2011 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2011.00075/full Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. CWF Cheng WenFang, LCN Lee ChienNan - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20053066734 Activated B cells mediate efficient expansion of rare antigen-specific T cells C Zentz, M Wiesner, S Man, B Frankenberger - Human immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885906006112 Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy C Thornburg, D Boczkowski, E Gilboa - Journal of , 2000 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2000/07000/induction_of_cytotoxic_t_lymphocytes_with.4.aspx A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers B Hu, R Wang, D Wu, R Long, J Fan, Z Hu - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/advs.202302340 Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide AX Yang, N Chong, Y Jiang, J Catalano, RK Puri - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086306

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP43487 H-YMLDL^QPETT-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".